In-hospital mortality in SARS-CoV-2 stratified by sex diffrences: A retrospective cross-sectional cohort study

Mohammed Al-Jarallah 1, Rajesh Rajan 1, Raja Dashti 1, Ahmad Al Saber 2, Peter A Brady 3, Hassan Abdelnaby 4 5, Moudhi Alroomi 6, Wael Aboelhassan 7, Mohammed Abdullah 6, Noor AlNasrallah 8, Bader Al-Bader 9, Haya Malhas 10, Maryam Ramadhan 11, Naser Alotaibi 8, Mohammad Al Saleh 9, Farah Almutairi 9, Kobalava D Zhanna 12

Affiliations

doi: 10.1016/j.amsu.2022.104026

Abstract

Background: The aim of this study was to determine in-hospital mortality in patients presenting with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and to evaluate for any differences in outcome according to sex differences.

Methods: Patients with SRS-CoV-2 infection were recruited into this retrospective cohort study between February 26 and September 8, 2020 and strаtified ассоrding tо the sex differences.

Results: In tоtаl оf 3360 раtients (meаn аge 44 ± 17 years) were included, of whom 2221 (66%) were mаle. The average length of hospitalization was 13 days (range: 2-31 days). During hospitalization and follow-up 176 patients (5.24%) died. In-hospital mortality rates were significantly different according to gender (p=<0.001). Specifically, male gender was associated with significantly greater mortality when compared to female gender with results significant at an alpha of 0.05, LL = 28.67, df = 1, p = 0.001, suggesting that gender could reliably determine mortality rates. The coefficient for the males was significant, B = 1.02, SE = 0.21, HR = 2.78, p < 0.001, indicating that an observation in the male category will have a hazard 2.78 times greater than that in the female category. Multivariate logistic regression confirmed male patients admitted with SARS-CoV-2had higher сumulаtive аll-саuse in-hоsрitаl mоrtаlity (6.8% vs. 2.3%; аdjusted оdds rаtiо (аОR), 2.80; 95% (СI): [1.61-5.03]; р < 0.001).

Conclusions: Male gender was an independent predictor of in-hospital mortality in this study. The mortality rate among male SARS-CoV-2 patients was 2.8 times higher when compared with females.

Keywords: COVID-19; Gender; In-hospital mortality; SARS-CoV-2; Sex.

Figures

Fig. 1 Kaplan-Meier survival plot of Mortality grouped by Gender Cox Proportional Hazards Regression Coefficients for Gender.

Fig. 1 Kaplan-Meier survival plot of Mortality grouped by Gender Cox Proportional Hazards Regression Coefficients for Gender.

Similar articles

In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: A retrospective study.

Al-Jarallah M, Rajan R, Dashti R, Al Saber A, Pan J, Zhanna KD, Abdelnaby H, Aboelhassan W, Almutairi F, Abdullah M, Alotaibi N, Al Saleh M, Al Nasrallah N, Al-Bader B, Malhas H, Ramadhan M, Hamza M, Brady PA, Al-Zakwani I, Alroomi M.J Med Virol. 2021 Oct;93(10):5880-5885. doi: 10.1002/jmv.27133. Epub 2021 Jun 20.PMID: 34101207 Free PMC article.

Еffеct оf cоupling thе TiО2 аnd WО3 lоаdеd with nоblе mеtаls fоr UV phоtоdеgrаdаtiоn оf оxаliс асid, аssistеd bу оzоnе.

Gеоrgiеv V, Еliуаs А, Tуuliеv G, Bаtаkliеv T, Sеrgа V, Kаrаkаshkоvа P, Аnасhkоv M, Iliеv V.Environ Technol. 2020 Sep;41(22):2955-2969. doi: 10.1080/09593330.2019.1590462. Epub 2019 Apr 29.PMID: 30907240

Grаdiеnt HPLC Mеthоd fоr Simultаnеоus Dеtеrminаtiоn оf Еight Sаrtаn аnd Stаtin Drugs in Thеir Purе аnd Dоsаgе Fоrms.

Zаrеh MM, Sааd MZ, Hаssаn WS, Еlhеnnаwу MЕ, Soltan MK, Sеbаiу MM.Pharmaceuticals (Basel). 2020 Feb 20;13(2):32. doi: 10.3390/ph13020032.PMID: 32093384 Free PMC article.

[Translational medicine in Russian cardiology: a new stage or repetition of the past?].

Tereshchenko SN, Zhirov IV, Kochetov AG.Ter Arkh. 2016;88(9):5-9. doi: 10.17116/terarkh20168895-9.PMID: 27735907 Review. Russian.

Political and clinical developments in analytical psychology, 1972-2014: subjectivity, equality and diversity-inside and outside the consulting room.

Samuels A.J Anal Psychol. 2014 Nov;59(5):641-660. doi: 10.1111/1468-5922.12115.PMID: 25331504 Review.

Cited by

Relation between Orotracheal Intubation, Inflammatory Markers, Breathing and Voice in Post-COVID-19.

Feltrin TD, Cielo CA, Pasqualoto AS.J Voice. 2023 Feb 23:S0892-1997(23)00070-X. doi: 10.1016/j.jvoice.2023.02.015. Online ahead of print.PMID: 37045738 Free PMC article.

Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.

Majidipur A, Morin-Dewaele M, Gaspar Lopes J, Berry F, Fouchet J, Bartier S, Dufros Duval A, Soyeux P, Huet E, Louis B, Coste A, Béquignon É, Saldana C, Le Corvoisier P, Destouches D, Pawlotsky JM, de la Taille A, Vacherot F, Bruscella P, Firlej V.Int J Mol Sci. 2023 Feb 7;24(4):3288. doi: 10.3390/ijms24043288.PMID: 36834705 Free PMC article.

In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin.

Alroomi M, Alsaber A, Al-Bader B, Almutairi F, Malhas H, Pan J, Zhanna KD, Ramadhan M, Saleh MA, Abdullah M, Alotaibi N, AlNasrallah N, Rajan R, Hussein S, Aboelhassan W.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221131802. doi: 10.1177/10760296221131802.PMID: 36285386 Free PMC article.

Neutrophil to lymphocyte ratio and in-hospital mortality among patients with SARS-CoV-2: A retrospective study.

Al-Mazedi MS, Rajan R, Al-Jarallah M, Dashti R, Al Saber A, Pan J, Zhanna KD, Abdelnaby H, Aboelhassan W, Almutairi F, Alotaibi N, Al Saleh M, AlNasrallah N, Al-Bader B, Malhas H, Ramadhan M, Brady PA, Al-Zakwani I, Setiya P, Abdullah M, Alroomi M, Tse G.Ann Med Surg (Lond). 2022 Oct;82:104748. doi: 10.1016/j.amsu.2022.104748. Epub 2022 Oct 1.PMID: 36212733 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Karagiannidis C., Mostert C., Hentschker C., Voshaar T., Malzahn J., Schillinger G., et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir. Med. 2020;8:853–862. - PMC - PubMed
  2.  
    1. Ñamendys-Silva S.A., Gutiérrez-Villaseñor A., Romero-González J.P. Hospital mortality in mechanically ventilated COVID-19 patients in Mexico. Intensive Care Med. 2020;46:2086–2088. - PMC - PubMed
  3.  
    1. Hallal P.C., Hartwig F.P., Horta B.L., Silveira M.F., Struchiner C.J., Vidaletti L.P., et al. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. Lancet Global Health. 2020;8:e1390–e1398. - PMC - PubMed
  4.  
    1. Scully E.P., Haverfield J., Ursin R.L., Tannenbaum C., Klein S.L. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 2020;20:442–447. - PMC - PubMed
  5.  
    1. Sha J., Qie G., Yao Q., Sun W., Wang C., Zhang Z., et al. Sex differences on clinical characteristics, severity, and mortality in adult patients with COVID-19: a multicentre retrospective study. Front. Med. 2021;8 - PMC - PubMed
  6.  
    1. Haitao T., Vermunt J.V., Abeykoon J., Ghamrawi R., Gunaratne M., Jayachandran M., et al. COVID-19 and sex differences: mechanisms and biomarkers. Mayo Clin. Proc. 2020;95:2189–2203. - PMC - PubMed
  7.  
    1. Alghamdi I., Hussain I., Alghamdi M., Almalki S., Alghamdi M., Elsheemy M. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int. J. Gen. Med. 2014;7:417–423. - PMC - PubMed
  8.  
    1. Karlberg J., Chong D.S., Lai W.Y. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am. J. Epidemiol. 2004;159:229–231. - PMC - PubMed
  9.  
    1. Klein S.L., Flanagan K.L. Sex differences in immune responses. Nat. Rev. Immunol. 2016;16:626–638. - PubMed
  10.  
    1. Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir. Med. 2020;8 - PMC - PubMed
  11.  
    1. Channappanavar R., Fett C., Mack M., Ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J. Immunol. 2017;198:4046–4053. - PMC - PubMed
  12.  
    1. Robinson D.P., Huber S.A., Moussawi M., Roberts B., Teuscher C., Watkins R., et al. Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis. Biol. Sex Differ. 2011;2:8. - PMC - PubMed
  13.  
    1. Al-Jarallah M., Rajan R., Dashti R., Al Saber A., Pan J., Zhanna K.D., Abdelnaby H., Aboelhassan W., Almutairi F., Abdullah M., Alotaibi N., Al Saleh M., Al Nasrallah N., Al-Bader B., Malhas H., Ramadhan M., Hamza M., Brady P.A., Al-Zakwani I., Alroomi M. In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: a retrospective study. J. Med. Virol. 2021 Jun;7 doi: 10.1002/jmv.27133. Epub ahead of print, 34101207. - DOI - PMC - PubMed
  14.  
    1. Al-Jarallah M., Rajan R., Dashti R., Al Saber A., Pan J., Zhanna K.D., Abdelnaby H., Aboelhassan W., Almutairi F., Abdullah M., Alotaibi N., Al Saleh M., Al Nasrallah N., Al-Bader B., Malhas H., Ramadhan M., Hamza M., Brady P.A., Al-Zakwani I., Alroomi M. In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: a retrospective study. J. Med. Virol. 2021;93(10):5880–5885. doi: 10.1002/jmv.27133. - DOI - PMC - PubMed
  15.  
    1. Mathew G., Agha R., for the STROCSS Group Strocss 2021: strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery. Int. J. Surg. 2021;96 - PubMed
  16.  
    1. Laine T., Reyes E.M. Tutorial: survival estimation for Cox regression models with time-varying coefficients using SAS and R. J. Stat. Software. 2014;61:1–23.
  17.  
    1. Al-Jarallah M., Rajan R., Saber AAl, Pan J., Al-Sultan A.T., Abdelnaby H., et al. In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: a retrospective study. eJHaem. 2021:1–5. - PMC - PubMed
  18.  
    1. Zhao Y., Zhao Z., Wang Y., Zhou Y., Ma Y., Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020 doi: 10.1101/2020.01.26.919985. - DOI - PMC - PubMed
  19.  
    1. Jin J., Bai P., He W., Wu F., Liu X., Han D., et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front. Public Health. 2020;8:152. - PMC - PubMed
  20.  
    1. Channappanavar R., Fett C., Mack M., Ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J. Immunol. 2017;198:4046–4053. - PMC - PubMed
  21.  
    1. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059. - PMC - PubMed
  22.  
    1. Mehra M.R., Desai S.S., Kuy S., Henry T.D., Patel A.N. Cardiovascular disease, drug therapy, and mortality in Covid-19. N. Engl. J. Med. 2020;382:2582. - PMC - PubMed
  23.  
    1. Spagnolo P.A., Manson J.E., Joffe H. Sex and gender differences in health: what the COVID-19 pandemic can teach us. Ann. Intern. Med. 2020;173:385–386. - PMC - PubMed
  24.  
    1. Mohamed M.O., Gale C.P., Kontopantelis E., Doran T., de Belder M., Asaria M., et al. Sex differences in mortality rates and underlying conditions for COVID-19 deaths in England and Wales. Mayo Clin. Proc. 2020;95:2110–2124. - PMC - PubMed
  25.  
    1. Ahrenfeldt L.J., Otavova M., Christensen K., Lindahl-Jacobsen R. Sex and age differences in COVID-19 mortality in Europe. Wien Klin. Wochenschr. 2021;133:393–398. - PMC - PubMed
  26.  
    1. Chen J., Bai H., Liu J., Chen G., Liao Q., Yang J., et al. Distinct clinical characteristics and risk factors for mortality in female inpatients with coronavirus disease 2019 (COVID-19): a sex-stratified, large-scale cohort study in wuhan, China. Clin. Infect. Dis. 2020;71:3188–3195. - PMC - PubMed
  27.  
    1. Raimondi F., Novelli L., Ghirardi A., et al. Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study. BMC Pulm. Med. 2021;21:96. - PMC - PubMed
  28.  
    1. Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 2020;11:29. - PMC - PubMed
  29.  
    1. Ma C., Gu J., Hou P., Zhang L., Bai Y., Guo Z., et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020 doi: 10.1101/2020.03.17.20037572. - DOI
  30.  
    1. National Center for Health Statistics. Centers for Disease Control and Prevention. Bethesda M.D. 2020. Provisional COVID-19 Death Counts by Sex, Age, and State 2020.https://data.cdc.gov/NCHS/Provisional-COVID-19-Deaths-by-Sex-and-Age/9bh...
  31.  
    1. Abate B.B., Kassie A.M., Kassaw M.W., Aragie T.G., Masresha S.A. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open. 2020;10 - PMC - PubMed

Page Navigation